FDA grants emergency use of Covid treatment given to Trump

“Authorizing these monoclonal antibody therapies may help outpatients avoid hospitalization and alleviate the burden on our health care s...

“Authorizing these monoclonal antibody therapies may help outpatients avoid hospitalization and alleviate the burden on our health care system,” FDA Commissioner Stephen Hahn said in a press release.

Background: President Donald Trump, who received the Regeneron antibody cocktail during his bout with Covid-19 in early October and referred to the drug as a “cure,” pressured the FDA to quickly authorize such treatments. Eli Lilly also won an emergency authorization for its antibody drug earlier this month. The authorizations may make it more difficult for Regeneron and Lilly to complete their ongoing studies, and for trials of other antibody treatments to attract participants.

Supply: Regeneron says it will have enough antibody doses for about 80,000 people by the end of the month. By the first week of January, doses are expected to be available for 200,000 patients in total, and 300,000 people by the end of that month.

The Trump administration has signed a $450 million deal with Regeneron to provide up to 300,000 doses of the drug cocktail at no cost to Americans. However, health care facilities can charge fees for the administration of the treatment.

But Regeneron CEO Len Schleifer has warned that there won’t be enough antibody treatment doses for everyone who needs one. Regeneron is working with Roche to boost manufacturing capacity and next year it could have as many as 2 million doses to treat Covid-19, or between 4 million and 8 million doses to help prevent people from getting sick.

What’s next: The Department of Health and Human Services will begin to distribute Regeneron’s antibody, potentially in a way that’s similar to Lilly’s antibody. The drug will be allocated on a weekly basis, and will be based on the number of coronavirus cases in each state.

Source link



Africa,799,Americas,4076,Art & Culture,14689,Arts,6433,Arts & Design,1614,Asia,3213,Automobile,454,Baseball,586,Basketball,476,Books,3825,Business,5268,Celebrity,2633,Cricket,648,Crime,158,Cryptocurrency,1487,Dance,647,Defense,836,Diplomatic Relations,2496,Economy,1100,Editorial,260,Education,1198,Elections,308,Energy & Environment,3059,Entertainment,22515,Environment,3565,Europe,4161,Faith & Religion,235,Family & Life,817,Fashion & Style,3189,Finance,19669,Food & Drink,3678,Football,1103,Games,97,Gossip,10289,Health & Fitness,4018,Health Care,930,Hockey,219,Home & Garden,920,Humour,994,Latin America,49,Lifestyle,16820,Media,527,Middle East,1477,Movies,1662,Music,2585,Opinion,2920,Other,11734,Other Sports,4971,Political News,11324,Political Protests,2324,Politics,17579,Real Estate,1789,Relationship,106,Retail,3116,Science,2571,Science & Tech,9842,Soccer,213,Space & Cosmos,334,Sports,12002,Technology,3372,Tennis,541,Theater,1640,Transportation,313,Travel,2521,TV,3627,US,58,US Sports,1481,Video News,3531,War & Conflict,1069,Weird News,998,World,16181,
Newsrust - US Top News: FDA grants emergency use of Covid treatment given to Trump
FDA grants emergency use of Covid treatment given to Trump
Newsrust - US Top News
Loaded All Posts Not found any posts VIEW ALL Readmore Reply Cancel reply Delete By Home PAGES POSTS View All RECOMMENDED FOR YOU LABEL ARCHIVE SEARCH ALL POSTS Not found any post match with your request Back Home Sunday Monday Tuesday Wednesday Thursday Friday Saturday Sun Mon Tue Wed Thu Fri Sat January February March April May June July August September October November December Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec just now 1 minute ago $$1$$ minutes ago 1 hour ago $$1$$ hours ago Yesterday $$1$$ days ago $$1$$ weeks ago more than 5 weeks ago Followers Follow THIS PREMIUM CONTENT IS LOCKED STEP 1: Share to a social network STEP 2: Click the link on your social network Copy All Code Select All Code All codes were copied to your clipboard Can not copy the codes / texts, please press [CTRL]+[C] (or CMD+C with Mac) to copy Table of Content